Pharmaceutical

Specialised Therapeutics partners with Treeway to license ALS drug

Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.

Aug 28, 2023 - 20:00
Specialised Therapeutics partners with Treeway to license ALS drug
Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.
Read the original article

Tags:

Previous Article

STAT+: Republican presidential candidates spar over abortion bans

Next Article

Phebra, University of Wollongong partner to develop cancer therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Indian pharma manufacturing: rising investment in Andhra Pradesh

Indian pharma manufacturing: rising investment in Andhr...

Apr 4, 2023

STAT+: An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

STAT+: An exit interview with Bristol Myers Squibb CEO ...

Oct 30, 2023

STAT+: Pharmalittle: This fall’s COVID booster rollout; approval for Pfizer’s RSV vaccine

STAT+: Pharmalittle: This fall’s COVID booster rollout;...

Aug 25, 2023